Galapagos NV
GLPG
$32.17
-$1.08-3.25%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/17/2026
-
Globe Newswire
3/10/2026
-
Globe Newswire
3/6/2026
-
Globe Newswire
3/5/2026
-
Globe Newswire
3/4/2026
-
Globe Newswire
3/3/2026
-
ETF Channel
2/24/2026
-
SeekingAlpha
2/24/2026
-
Seeking Alpha: Transcripts
2/24/2026
-
MarketBeat
2/24/2026
-
MarketBeat
2/23/2026
-
Globe Newswire
2/19/2026
-
Globe Newswire
2/18/2026
-
Ticker Report
2/17/2026
-
TipRanks Financial Blog
2/16/2026
-
Globe Newswire
2/10/2026
-
Globe Newswire
1/5/2026
-
TipRanks Financial Blog
1/5/2026
-
Globe Newswire
12/18/2025
-
Globe Newswire
12/12/2025
-
Nasdaq News: Stocks
12/12/2025
-
ETF Channel
12/8/2025
-
Globe Newswire
12/4/2025
-
MarketBeat
12/1/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Monday, February 23, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
32 1 534 29 00
Address
Generaal De Wittelaan L11 A3
Mechelen, 2800
Mechelen, 2800
Country
Year Founded
Business Description
Sector
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667 that has...
more